Articles by Disease (Prostate Cancer)

Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development

Journal: Current Pharmaceutical Design
Volume: 12
Page: 2609-2622
Author(s): Philip Lazarovici, Cezary Marcinkiewicz and Peter I. Lelkes

Angiogenesis Inhibitors: Perspectives for Medical, Surgical and Radiation Oncology

Journal: Current Pharmaceutical Design
Volume: 12
Page: 2623-2630
Author(s): C. Verhoef, J. H.W. de Wilt and H. M.W. Verheul

Imaging of Tumor Angiogenesis: Current Approaches and Future Prospects

Journal: Current Pharmaceutical Design
Volume: 12
Page: 2661-2672
Author(s): Heike E. Daldrup-Link, Gerhard H. Simon and Robert C. Brasch

Natural Product-Derived Small Molecule Activators of Hypoxia-Inducible Factor-1 (HIF-1)

Journal: Current Pharmaceutical Design
Volume: 12
Page: 2673-2688
Author(s): Dale G. Nagle and Yu-Dong Zhou

Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 6
Page: 835-844
Author(s): Hiroji Uemura, Hitoshi Ishiguro and Yoshinobu Kubota

Retinoids in Clinical Use

Journal: Medicinal Chemistry
Volume: 2
Page: 431-438
Author(s): Vincent C. O. Njar, Lalji Gediya, Puranik Purushottamachar, Panka Chopra, Aashvini Belosay and Jyoti B. Patel

Design, Synthesis and In Vitro Evaluation of 4-Androstene-3,17-dione/Adenosine Hybrid Compounds as Bisubstrate Inhibitors of Type 3 17β-Hydroxysteroid Dehydrogenase

Journal: Medicinal Chemistry
Volume: 2
Page: 329-347
Author(s): Marie Berube, Yannick Laplante and Donald Poirier